NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
Aduro Clean Technologies Announces Partial Exercise of Over-Allotment Option
LONDON, Ontario, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc.…
Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds
November 13, 2024 12:22 ET | Source: Cyclacel BERKELEY HEIGHTS, N.J., Nov.…
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO,…